comparemela.com

Latest Breaking News On - Anavex life sciences corp research business - Page 2 : comparemela.com

Anavex Life Sciences (AVXL) Announces Late-Breaking Presentation of Phase 2b/3 Data of Oral ANAVEX®2-73 (blarcamesine) for Early Alzheimer s Disease at the Upcoming CTAD Congress

Anavex Life Sciences (AVXL) Announces Late-Breaking Presentation of Phase 2b/3 Data of Oral ANAVEX®2-73 (blarcamesine) for Early Alzheimer s Disease at the Upcoming CTAD Congress
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Anavex Life Sciences Announces Issuance of U S Patent Covering ANAVEX®2-73 (blarcamesine) for Neurodevelopmental Disorders Therapy

Anavex Life Sciences Announces Issuance of U S Patent Covering ANAVEX®2-73 (blarcamesine) for Neurodevelopmental Disorders Therapy
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Anavex Life Sciences to Announce Fiscal 2022 Third Quarter Financial Results on Tuesday August 9, 2022

Anavex Life Sciences to Announce Fiscal 2022 Third Quarter Financial Results on Tuesday August 9, 2022
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

vimarsana © 2020. All Rights Reserved.